Received Jun 2, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
patient received the first dose of Shingrix vaccine in 2020 and now is scheduled for their 2nd dose.; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a patient who did not receive Herpes zoster (Shingrix) solution for injection for prophylaxis. Previously administered products included Shingrix (first dose of Shingrix vaccine in 2020). The patient did not receive the 2nd dose of Shingrix. The patient experienced incomplete course of vaccination (Verbatim: patient received the first dose of Shingrix vaccine in 2020 and now is scheduled for their 2nd dose.). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 29-MAY-2026 The pharmacist reported a patient received the first dose of Shingrix vaccine in 2020 and now scheduled for their 2nd dose. The pharmacist could not provide patient details, batch/lot number, date of vaccination, or expiration date of the first Shingrix vaccine dose. Patient details and first Shingrix vaccine details unknown to the pharmacist and they could not provide the information.